Hepatotoxicity associated with cyclosporine monitoring using C2 recommendations in adults renal recipients receiving ketoconazole.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Transplantation Proceedings

• Publication date

  2005-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.TRANSPROCEED.2004.09.011PMID 15866677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study.

  2001cited by this paper
• Optimization of cyclosporine exposure utilizing C(2) level monitoring in de novo renal transplant recipients: the Toronto General Hospital experience.

  2001cited by this paper
• Relationship of pharmacokinetics to clinical outcomes.

  1999cited by this paper
• Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants.

  1998cited by this paper
• [Conversion from +Sandimmune to Neoral in kidney transplant recipients treated with cyclosporine and ketoconazole].

  1997cited by this paper
• CYCLOSPORINE A HEPATOTOXICITY: EFFECT OF PROLONGED TREATMENT WITH CYCLOSPORINE ON BILIARY LIPID SECRETION IN THE RAT

  1995cited by this paper
• Hepatotoxicity of transplant immunosuppressive agents.

  1995cited by this paper
• Drug-induced hepatotoxicity.

  1995cited by this paper
• Role of glutathione in cyclosporine A in vitro hepatotoxicity.

  1994cited by this paper
• Increased susceptibility for CsA-induced hepatotoxicity in kidney graft recipients with chronic viral hepatitis C.

  1993cited by this paper
• Cyclosporine and ketoconazole.

  1984cited by this paper

• Unveiling the Masquerade: Pulmonary Mycosis Mimicking Pulmonary Malignancy- A Case Series

  2024cites this paper
• Efficacy and safety of ketoconazole combined with calmodulin inhibitor in solid organ transplantation: A systematic review and meta‐analysis

  2019cites this paper
• Apport des modèles PBPK dans l'optimisation thérapeutique des inhibiteurs des calcineurines en transplantation

  2012cites this paper
• Cyclosporine level at the second hour in pediatric hematopoietic stem cell transplant patients.

  2011cites this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients.

  2009cites this paper
• Analysis of liver function in renal transplant recipients undergoing C2‐monitoring for cyclosporine

  2008cites this paper
• Prediction of cyclosporine A blood levels: an application of the adaptive-network-based fuzzy inference system (ANFIS) in assisting drug therapy

  2008cites this paper
• 27 Antifungal drugs

  2007cites this paper
• Converting to a generic formulation of mycophenolate mofetil in stable kidney transplant recipients: 1 year of drug surveillance and outcome.

  2007cites this paper
• Drug-induced liver disease

  1990cites this paper